Blood Purification Equipment Global Market Report 2024: Market Forecast to Reach $28.71 Billion by 2028 With Innovations Driving Growth - Long-term Forecasts to 2033
February 13, 2024 11:40 ET
|
Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Blood Purification Equipment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. According to this in-depth...
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
February 08, 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
January 17, 2024 07:15 ET
|
CytoSorbents
CytoSorb Blood Purification Results in Significant Decrease in Organ Failure and Dysfunction in Groundbreaking Heart Transplant Randomized Controlled Trial
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
December 13, 2023 09:15 ET
|
CytoSorbents
CytoSorbents Strengthens Balance Sheet with $10.3M Registered Direct Offering. Insiders invest $435,000
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
November 09, 2023 16:15 ET
|
CytoSorbents
PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents to Present at the 8th Annual Dawson James Conference
October 05, 2023 07:00 ET
|
CytoSorbents
CytoSorbents to Highlight Company Progress at Dawson James Small Cap Investor Growth Conference
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
September 27, 2023 07:00 ET
|
CytoSorbents
CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
September 11, 2023 11:32 ET
|
CytoSorbents
PRINCETON, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
September 01, 2023 16:43 ET
|
CytoSorbents
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
August 31, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...